ELANCO ANIMAL HEALTH INC (ELAN) Stock Analyst Earnings Estimates
NYSE:ELAN - New York Stock Exchange, Inc. - US28414H1032 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.764B 45.64% | 4.411B -7.41% | 4.417B 0.14% | 4.513B 2.17% | 4.623B 2.44% | 4.826B 4.39% | 5.105B 5.78% | 5.324B 4.29% | 5.37B 0.86% | 5.574B 3.80% | 5.797B 4.00% | |
| EBITDA YoY % growth | 1.02B 134.54% | 1.066B 4.51% | 1.02B -4.32% | 925.58M -9.26% | 915.13M -1.13% | 1.016B 11.02% | 1.195B 17.62% | 1.249B 4.52% | 1.326B 6.16% | 1.433B 8.07% | N/A | |
| EBIT YoY % growth | 304M 470.73% | 384M 26.32% | 326M -15.10% | 770.08M 136.22% | 694.76M -9.78% | 787M 13.28% | 1.044B 32.66% | 1.095B 4.89% | 1.137B 3.84% | 1.234B 8.53% | 1.301B 5.43% | |
| Operating Margin | 6.38% | 8.71% | 7.38% | 17.06% | 15.03% | 16.31% | 20.45% | 20.57% | 21.17% | 22.14% | 22.44% | |
| EPS YoY % growth | 1.05 123.40% | 1.11 5.71% | 0.89 -19.82% | 0.94 5.06% | 0.92 -1.63% | 1.07 16.46% | 1.32 23.55% | 1.48 11.56% | 1.53 3.63% | 1.68 10.00% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.15 92.74% | 0.31 -9.58% | 0.28 -7.04% | 0.15 11.89% | 0.18 14.77% | 0.36 17.23% | 0.31 12.17% | 0.16 12.20% | 0.20 11.43% |
| Revenue Q2Q % growth | 1.03B -0.48% | 1.235B 2.49% | 1.202B 1.52% | 1.097B 6.50% | 1.083B 5.15% | 1.301B 5.34% | 1.248B 3.83% | 1.15B 4.83% | 1.126B 3.97% |
| EBITDA Q2Q % growth | 183.26M -73.97% | 283.53M -5.17% | 258.9M -41.56% | 173.91M -64.72% | 189.43M 3.37% | 320.2M 12.93% | 284.79M 10.00% | 188.59M 8.44% | 208M 9.80% |
| EBIT Q2Q % growth | 148.28M 1,382.80% | 249.32M 87.46% | 221.47M 92.58% | 141.02M 2,920.40% | 162.74M 9.75% | 284.28M 14.02% | 248.94M 12.40% | 150.01M 6.37% | 173.25M 6.46% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.13 -27.78% | 0.12 | 0.01 | 7.92% |
| Q2 2024 Q2Q % growth | 0.30 66.67% | 0.25 | 0.05 | 22.24% |
| Q1 2024 Q2Q % growth | 0.34 -24.44% | 0.27 | 0.07 | 26.41% |
| Q4 2023 Q2Q % growth | 0.08 -57.89% | 0.11 | -0.03 | -26.01% |
| Q3 2023 Q2Q % growth | 0.18 -10.00% | 0.12 | 0.06 | 48.43% |
| Q2 2023 Q2Q % growth | 0.18 -50.00% | 0.05 | 0.13 | 269.34% |
| Q1 2023 Q2Q % growth | 0.45 25.00% | 0.29 | 0.16 | 53.01% |
| Q4 2022 Q2Q % growth | 0.19 -9.52% | 0.13 | 0.06 | 45.19% |
| Q3 2022 Q2Q % growth | 0.20 5.26% | 0.16 | 0.04 | 23.32% |
| Q2 2022 Q2Q % growth | 0.36 28.57% | 0.26 | 0.10 | 38.95% |
| Q1 2022 Q2Q % growth | 0.36 -2.70% | 0.36 | 0.00 | -0.02% |
| Q4 2021 Q2Q % growth | 0.21 75.00% | 0.17 | 0.04 | 20.26% |
| Q3 2021 Q2Q % growth | 0.19 46.15% | 0.17 | 0.02 | 12.71% |
| Q2 2021 Q2Q % growth | 0.28 211.11% | 0.27 | 0.01 | 4.51% |
| Q1 2021 Q2Q % growth | 0.37 184.62% | 0.23 | 0.14 | 59.86% |
| Q4 2020 Q2Q % growth | 0.12 -47.83% | 0.09 | 0.03 | 34.67% |
| Q3 2020 Q2Q % growth | 0.13 -56.67% | 0.12 | 0.01 | 5.33% |
| Q2 2020 Q2Q % growth | 0.09 -67.86% | 0.06 | 0.03 | 57.34% |
| Q1 2020 Q2Q % growth | 0.13 -48.00% | 0.24 | -0.11 | -46.39% |
| Q4 2019 Q2Q % growth | 0.23 | 0.23 | 0.00 | -1.78% |
| Q3 2019 Q2Q % growth | 0.30 | 0.26 | 0.04 | 14.81% |
| Q2 2019 Q2Q % growth | 0.28 | 0.26 | 0.02 | 7.27% |
| Q1 2019 Q2Q % growth | 0.25 | 0.23 | 0.02 | 6.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.03B -3.56% | 1.055B | -25M | -2.37% |
| Q2 2024 Q2Q % growth | 1.184B 12.02% | 1.174B | 10M | 0.85% |
| Q1 2024 Q2Q % growth | 1.205B -4.14% | 1.198B | 7M | 0.58% |
| Q4 2023 Q2Q % growth | 1.035B 5.50% | 1.022B | 13M | 1.27% |
| Q3 2023 Q2Q % growth | 1.068B 4.09% | 1.06B | 8M | 0.75% |
| Q2 2023 Q2Q % growth | 1.057B -10.04% | 1.056B | 1M | 0.09% |
| Q1 2023 Q2Q % growth | 1.257B 2.61% | 1.202B | 55M | 4.58% |
| Q4 2022 Q2Q % growth | 981M -11.78% | 1.001B | -20M | -2.00% |
| Q3 2022 Q2Q % growth | 1.026B -9.28% | 1.053B | -27M | -2.56% |
| Q2 2022 Q2Q % growth | 1.175B -8.13% | 1.205B | -30M | -2.49% |
| Q1 2022 Q2Q % growth | 1.225B -1.37% | 1.244B | -19M | -1.53% |
| Q4 2021 Q2Q % growth | 1.112B -2.23% | 1.125B | -13M | -1.16% |
| Q3 2021 Q2Q % growth | 1.131B 27.14% | 1.105B | 26M | 2.35% |
| Q2 2021 Q2Q % growth | 1.279B 118.15% | 1.267B | 12M | 0.95% |
| Q1 2021 Q2Q % growth | 1.242B 88.84% | 1.183B | 59M | 4.99% |
| Q4 2020 Q2Q % growth | 1.137B 44.52% | 1.078B | 59.4M | 5.51% |
| Q3 2020 Q2Q % growth | 889.6M 15.34% | 927.52M | -37.92M | -4.09% |
| Q2 2020 Q2Q % growth | 586.3M -24.99% | 601.22M | -14.92M | -2.48% |
| Q1 2020 Q2Q % growth | 657.7M -10.04% | 732.78M | -75.08M | -10.25% |
| Q4 2019 Q2Q % growth | 787M | 807.33M | -20.33M | -2.52% |
| Q3 2019 Q2Q % growth | 771.3M | 780.73M | -9.43M | -1.21% |
| Q2 2019 Q2Q % growth | 781.6M | 798.54M | -16.94M | -2.12% |
| Q1 2019 Q2Q % growth | 731.1M | 758.4M | -27.3M | -3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.47% | -6.92% | -0.14% | -0.53% |
| Revenue | -0.29% | -0.19% | -0.02% | -0.02% |